Examination of the usefulness of DPP-4 inhibitor in the treatment of type 2 diabetes
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000011862
- Lead Sponsor
- aka Kinen Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1)Under insulin treatment (diabetic ketoacidosis , diabetic coma , type 1 diabetes , etc) 2)Has allergy to vildagliptin 3)Severe liver dammge 4)After severe infection,operation or injury 5)Patient who was considered to be appropriate to this study by attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Surrogate marker(inflammation and oxidative stress) Continuous Glucose Monitoring
- Secondary Outcome Measures
Name Time Method